Post-IPO Equity - BioCryst Pharmaceuticals
Investment Firm
Overview
BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.
Announced Date
Nov 22, 2021
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
BioCryst Pharmaceuticals raised $350000000 on 2021-11-22 in Post-IPO Equity
BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina.
Company Funding History
18
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 22, 2021 |  Post-IPO Equity - BioCryst Pharmaceuticals | 2 | - | 350.0M |
| Apr 17, 2023 | Post-IPO Debt - BioCryst Pharmaceuticals | 1 | - | 450.0M |
| Aug 13, 2014 | Grant - BioCryst Pharmaceuticals | 2 | - | 4.1M |
| Jun 23, 2014 | Post-IPO Equity - BioCryst Pharmaceuticals | - | 1.9M |
Recent Activity
There is no recent news or activity for this profile.